Creative Foam Corporation has acquired AccuMED, a prominent medical contract manufacturing division of Lear Corporation, enhancing its capabilities in the medical sector.
Target Company Overview
AccuMED, a division of Lear Corporation (NYSE: LEA), is a prominent provider of medical contract manufacturing and engineering services, primarily focusing on textile-based Class I and Class II medical devices. With a commitment to quality and excellence, AccuMED has established partnerships with leading medical Original Equipment Manufacturers (OEMs) both in the United States and globally. The company is headquartered in the Dominican Republic, where it has maintained ISO 13485 and FDA registered facilities for over 20 years, employing approximately 1,400 professionals dedicated to delivering superior manufacturing solutions.
Industry Overview
The medical manufacturing industry in the Dominican Republic is thriving, primarily due to the country's strategic geographical location and favorable economic conditions. Over the past decade, the Dominican Republic has established itself as a hub for medical device manufacturing, attracting numerous international firms seeking to leverage its cost-effective labor force. This booming sector is bolstered by the government's commitment to creating a business-friendly environment, encouraging foreign investment and technological advancements.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Moreover, the Dominican Republic's medical device industry benefits from a robust infrastructure that supports efficient manufacturing and distribution processes. The country's w
Similar Deals
Novartis AG → Avidity Biosciences, Inc.
2026
XenoTherapeutics, Inc. → Repare Therapeutics Inc.
2026
MSD (Merck & Co., Inc.) → Cidara Therapeutics, Inc.
2026
Creative Foam Corporation
invested in
AccuMED
in 2025
in a Merger deal